A

Researcher Profile

Ann Sturdy

4

Publications

6,391

Citations

10

Co-Authors

2

Active Years

Publications

Open Access Journal Article The Lancet Infectious Diseases Aug 01, 2022

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

Alasdair P S Munro · Shuo Feng · Leila Janani · Victoria Cornelius +305 more

10.1016/s1473-3099(22)00271-7 153 citations

Open Access Journal Article The Lancet May 01, 2021

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani · Ali Abbas · Fatima Abbas · Mustafa Abbas +6331 more

10.1016/s0140-6736(21)00676-0 1,504 citations

Open Access Journal Article The Lancet Jan 01, 2021

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey · Sue Ann Costa Clemens · Shabir A Madhi · Lily Y Weckx +759 more

10.1016/s0140-6736(20)32661-1 4,121 citations

Open Access Journal Article The Lancet Dec 01, 2021

Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial

Alasdair P S Munro · Leila Janani · Victoria Cornelius · Parvinder K Aley +304 more

10.1016/s0140-6736(21)02717-3 613 citations

Publication Timeline

2022

1

2021

3

Frequent Co-Authors

Hannah Robinson

Karen Bisnauthsing